Zhang Zhen Hua, Chen Zheng Fu, Song Run Da, Jiang Tao
China-Japan Union Hospital of Jilin University, Changchun, China.
Obes Surg. 2025 Jan;35(1):271-279. doi: 10.1007/s11695-024-07642-2. Epub 2024 Dec 21.
To compare the mid-term efficacy and postoperative complications of two common bariatric procedures-single anastomotic duodeno-ileal bypass with sleeve gastrectomy (SADI-S) and sleeve gastrectomy (SG)-in treating obesity and metabolic syndrome.
Data from 186 patients undergoing SADI-S or SG between September 2013 and October 2021 were retrospectively analyzed. Propensity score matching (PSM) was applied in a 1:1 ratio, resulting in 78 patients included in the final analysis (39 per group). Differences between groups were compared regarding weight loss outcomes (weight, BMI, waist circumference, waist-to-height ratio, %TWL, %EWL), metabolic syndrome remission rates (diabetes, hypertension, hyperuricemia, dyslipidemia, fatty liver), and postoperative complications (bone density abnormalities, anemia, gallstones).
Following matching, the SADI-S group achieved significantly greater weight loss (P < 0.05), particularly in %TWL and %EWL. Additionally, the SADI-S group exhibited greater efficacy in metabolic syndrome remission (diabetes, hypertension, dyslipidemia). However, the SADI-S group showed a higher incidence of postoperative bone mineral density abnormalities (P < 0.05) and more severe anemia compared to the SG group.
While SADI-S demonstrates superior weight loss and metabolic disease remission, SG may be preferable for patients with concurrent bone density issues,a higher risk of anemia,or nutritional deficiencies. Further optimization of postoperative management is recommended to reduce these complications.
比较两种常见的减肥手术——单吻合十二指肠回肠旁路术联合袖状胃切除术(SADI-S)和袖状胃切除术(SG)——治疗肥胖症和代谢综合征的中期疗效及术后并发症。
回顾性分析2013年9月至2021年10月期间接受SADI-S或SG手术的186例患者的数据。采用倾向得分匹配法(PSM)按1:1比例进行匹配,最终纳入78例患者进行分析(每组39例)。比较两组在体重减轻结果(体重、BMI、腰围、腰高比、%TWL、%EWL)、代谢综合征缓解率(糖尿病、高血压、高尿酸血症、血脂异常、脂肪肝)及术后并发症(骨密度异常、贫血、胆结石)方面的差异。
匹配后,SADI-S组体重减轻更为显著(P < 0.05),尤其是在%TWL和%EWL方面。此外,SADI-S组在代谢综合征缓解(糖尿病、高血压、血脂异常)方面疗效更佳。然而,与SG组相比,SADI-S组术后骨矿物质密度异常的发生率更高(P < 0.05),贫血也更严重。
虽然SADI-S在体重减轻和代谢疾病缓解方面表现更优,但对于合并骨密度问题、贫血风险较高或存在营养缺乏的患者,SG可能更为合适。建议进一步优化术后管理以减少这些并发症。